Structural heart disease refers to cardiac defects that are congenital in nature and can also be acquired through wear & tear of heart valves or chambers of the heart. Rapid advancements in the medical field have replaced the open heart surgical procedures with non-surgical minimally invasive procedures such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR).
Currently, the global structural heart devices market is growing at a steady pace owing to the rise in incidence of structural heart diseases (aortic stenosis and mitral regurgitation) and development of minimally invasive technologies. According to the Micro Interventional Devices, Inc., about 60 million people in the U.S. suffer from structural heart defects. Moreover, as per the National Heart, Lung and Blood Institute, more than 35,000 babies are born with congenital heart defects in the U.S. These estimates are expected to boost the demand for structural heart devices during the forecast period. High cost of surgeries, risks associated with these surgeries, and lack of skilled cardiologists restrict this market growth. However, emerging markets (India and China) and increase in demand for structural heart procedures are expected to provide lucrative opportunities to the key players. The structural heart devices market is projected to reach $12,076 million by 2022 from $6,006 million in 2015, growing at a CAGR of 10.5% from 2016 to 2022.
The report segments the market based on product type, indication, age group, and geography. Based on product type, the market is bifurcated into repair devices (annuloplasty rings, heart valve balloons, and occluders) and replacement valves (mechanical and tissue heart valves]. Based on indication, it is divided into atrial septal defect (ASD), patent foramen ovale (PFO), and ventricular septal defect (VSD), aortic valve stenosis, and others. In terms of age group, it is further categorized as pediatrics and adults. The pediatrics’ age group is segmented into newborns (0–5 months), infants (6 months to 12 months), toddlers (1–2 years), preschoolers (3–5 years), school-aged children (6–12 years), and adolescents (13–18 years). The adult age group market is further segmented into young adults (19–24 years), adulthood (25–39 years), middle-aged (40–59 years), older people/old age (60–84 years), and very old (85+ years). Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the structural heart devices market, along with the current trends and future estimations to elucidate the imminent investment pockets.
It presents a quantitative analysis from 2014 to 2022 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on products helps to understand the type of devices used to treat structural heart diseases.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Comprehensive analysis of all geographical regions determines the prevailing opportunities in these regions.
Key players and their strategies are analyzed to understand the competitive outlook of the overall market.
Extensive analysis is conducted by following key product positioning and monitoring the top contenders within the market framework.
Request a sample of this report at http://www.orbisresearch.com/contacts/request-sample/213912 .
KEY MARKET SEGMENTS
Heart Valve Balloons
Mechanical Heart Valves
Tissue Heart Valves
Atrial Septal Defect (ASD)
Ventricular Septal Defect (VSD)
Patent Foramen Ovale (PFO)
Aortic Valve Stenosis
By Age Group
Newborns (0–5 months)
Infants (6 months to 12 months)
Toddlers (1–2 years)
Preschoolers (3–5 years)
School-aged children (6–12 years)
Young Adults (19–24 years)
Adulthood (25–39 years)
Middle-aged Persons (40–59 years)
Older People/Old Age (60–84 years)
Very Old (85+ years)
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
List of key players profiled in the report
St. Jude Medical, Inc.
Medical Technology Est.
Boston Scientific Corporation
Micro Interventional Devices, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
List of other players in the value chain (profiles not included in the report)
Corvia Medical, Inc.
Lepu Medical Technology (Beijing) Co., Ltd.
Place a direct purchase order on this report at http://www.orbisresearch.com/contact/purchase/213912 .
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.